Friday, May 03, 2013

Cancer drug Avastin tied to cases of flesh-eating disease in Canada

The cancer-treatment drug Avastin has been linked to 52 cases of flesh-eating disease worldwide, including one that resulted in death in Canada.
Health Canada issued a warning in conjunction with the drug's manufacturer, Hoffmann-La Roche Ltd., echoing an earlier one from the U.S. Food and Drug Administration. It offered no specific details on two Canadian cases.
People who have diabetes or cancer have a greater risk of developing necrotizing fasciitis because their immune system responses are lowered.
The FDA issued a similar warning in mid-March, indicating that cases have mainly been seen in people who had wound-healing complications, gastrointestinal perforations or fistulas.
Health Canada and Roche.